Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-02

Clinical Trial Update: tVNS and Obesity-related Mechanisms [NA]

View source ↗

Summary

Clinical trial update on transcutaneous vagus nerve stimulation (tVNS) exploring obesity-related mechanisms; the study is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcutaneous vagus nerve stimulation (tVNS) (transcutaneous vagus nerve stimulation)

Snippet

Sponsor: University of Bonn | Conditions: Overweight/Obesity (BMI: 27 and 35 kg/m2) | NA | Status: ENROLLING_BY_INVITATION